Galectin Therapeutics reported $165.3M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Merck USD 261.26B 51.62B Dec/2025